Fingerprint
Dive into the research topics of 'Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): A phase 2, single-arm trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically